Update Reimbursement Scheme Jardiance® 10mg - Chronic Kidney Disease
From February 1, 2024, the use of Jardiance® (empagliflozin) in adult patients with chronic kidney disease, with and without...
Reimbursement Scheme Kesimpta®
The health insurer does not fully reimburse Kesimpta® 20mg solution for injection in pre-filled pen. The producer of this medicine...
Update Reimbursement Scheme Forxiga® 10mg and Xigduo® 5mg
TBR Nederland hereby informs you that from now on the conditions regarding the Reimbursement Scheme Forxiga® 10mg and Xigduo® 5mg...
Reimbursement Scheme Adhesa®
The health insurer does not fully reimburse Adhesa® 5 mg. The producer of this medicine has therefore asked TBR Nederland to...
Update Reimbursement Scheme Adempas®
As off May 31st 2023, the reimbursement for Adempas® 0.5 mg and 1.0 mg is now also indicated for the treatment of PAH in pediatric...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine